Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia

Conditions:   Presbyopia;   Near Vision;   Miosis;   Eye Diseases Interventions:   Drug: Aceclidine+Brimonidine combination ophthalmic solution;   Drug: Aceclidine ophthalmic solution;   Drug: Placebo (Vehicle) ophthalmic solution Sponsors:   Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.;   LENZ Therapeutics, Inc Not yet recruiting

Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials